person · Reporting owner

Templeton Mary B Esq

Disclosed activity across 1 company

Tapewire entity: 148948
SEC CIK: 0001530067

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
WINDTREE THERAPEUTICS INC /DE/WINT · Entity 8761	SVP, Gen Counsel & Corp Sec	May 22, 2020	May 28, 2020

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

WINDTREE THERAPEUTICS INC /DE/

Report date May 22, 2020 · Filed May 28, 2020

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,134	Reported balance After 2020-05-22 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2020-05-22 · Purchase · Acquired 1,103 · Balance 1,134 F1: Adjusted to reflect 1-for-3 reverse stock split effective April 29, 2020.
Common Stock WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $7.98 · Expires 2025-05-22	Direct	1,103	Reported balance After 2020-05-22 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2020-05-22 · Purchase · Acquired 1,103 · Balance 1,103 F3: Issued in connection with the purchase of shares of common stock on May 22, 2020 as reported above.
Common StockSEC Table I · non-derivative	IndirectBy Trust	332	Reported balance Holding disclosure · report date 2020-05-22 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 332 F1: Adjusted to reflect 1-for-3 reverse stock split effective April 29, 2020. F2: Holding amount represents issuer's matching stock contribution pursuant to 401(k) plan.

Filing footnotes · ownership attribution and instrument terms

F1: Adjusted to reflect 1-for-3 reverse stock split effective April 29, 2020.

F2: Holding amount represents issuer's matching stock contribution pursuant to 401(k) plan.

F3: Issued in connection with the purchase of shares of common stock on May 22, 2020 as reported above.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 22, 2020 Filed May 28, 2020 01:56 UTC	WINDTREE THERAPEUTICS INC /DE/ WINT · Entity 8761	PurchaseCommon Stock Warrants · Derivative	1,103	$0.00 Strike: $7.98	$0.00	Disclosure SEC source: 0001437749-20-011879 · rdgdoc.xml · derivative · entry 3 Templeton Mary B Esq · CIK 0001530067 · SVP, Gen Counsel & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Common Stock · 1,103 shares Expires 2025-05-22 F3 · price: Issued in connection with the purchase of shares of common stock on May 22, 2020 as reported above. Read SEC document
May 22, 2020 Filed May 28, 2020 01:56 UTC	WINDTREE THERAPEUTICS INC /DE/ WINT · Entity 8761	PurchaseCommon Stock	1,103	$7.25	$7,996.75	Disclosure SEC source: 0001437749-20-011879 · rdgdoc.xml · nonDerivative · entry 1 Templeton Mary B Esq · CIK 0001530067 · SVP, Gen Counsel & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,134 F1 · balance_after: Adjusted to reflect 1-for-3 reverse stock split effective April 29, 2020. Read SEC document
March 19, 2019 Filed Mar 21, 2019 20:37 UTC	WINDTREE THERAPEUTICS INC /DE/ WINT · Entity 8761	GrantEmployee Stock Option (Right to Buy) · Derivative	40,000	$0.00 Strike: $4.30	$0.00	Disclosure SEC source: 0001437749-19-005432 · rdgdoc.xml · derivative · entry 3 Templeton Mary B Esq · CIK 0001530067 · SVP, Gen Counsel & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-03-19 F2 · derivative.exercise_date: This employee stock option shall vest in a series of three successive, equal installments beginning with the first anniversary of the grant. Read SEC document
December 24, 2018 Filed Dec 28, 2018 00:28 UTC	WINDTREE THERAPEUTICS INC /DE/ WINT · Entity 8761	GrantEmployee Stock Option (Right to Buy) · Derivative	421,906	$0.00 Strike: $4.22	$0.00	Disclosure SEC source: 0001437749-18-022680 · rdgdoc.xml · derivative · entry 3 Templeton Mary B Esq · CIK 0001530067 · SVP, Gen Counsel & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,906 Underlying: Common Stock · 421,906 shares Expires 2028-12-24 F3 · derivative.exercise_date: This employee stock option shall vest in a series of three successive, annual installments beginning with the first anniversary of the grant date. Read SEC document
March 01, 2017 Filed Mar 3, 2017 21:26 UTC	WINDTREE THERAPEUTICS INC /DE/ WINT · Entity 8761	GrantIncentive Stock Option (Right to Buy) · Derivative	50,000	$0.00 Strike: $1.23	$0.00	Disclosure SEC source: 0001437749-17-003783 · rdgdoc.xml · derivative · entry 3 Templeton Mary B Esq · CIK 0001530067 · SVP, Gen Counsel & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-03-01 F1 · derivative.exercise_date: This employee stock option shall vest in a series of three successive, equal installments beginning with the first anniversary of the grant. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.